SSA
VKTX icon

Schonfeld Strategic Advisors’s Viking Therapeutics VKTX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
+53,683
New +$1.73M 0.01% 1046
2026
Q1 		– Sell
-67,647
Closed -$2.38M – 2711
2025
Q4 		$2.38M Sell
67,647
-176,812
-72% -$6.26M 0.01% 814
2025
Q3 		$6.42M Buy
+244,459
New +$7.29M 0.04% 496
2025
Q2 		– Sell
-228,474
Closed -$5.52M – 2575
2025
Q1 		$5.52M Buy
+228,474
New +$7.22M 0.03% 495
2024
Q4 		– Sell
-51,109
Closed -$3.24M – 2418
2024
Q3 		$3.24M Buy
51,109
+22,467
+78% +$1.32M 0.02% 694
2024
Q2 		$1.52M Sell
28,642
-5,007
-15% -$328K 0.01% 1027
2024
Q1 		$2.76M Buy
+33,649
New +$1.5M 0.02% 878
2023
Q4 		– Sell
-53,900
Closed -$597K – 2251
2023
Q3 		$597K Buy
53,900
+7,947
+17% +$114K ﹤0.01% 1161
2023
Q2 		$745K Sell
45,953
-284,402
-86% -$5.96M 0.01% 1080
2023
Q1 		$5.5M Buy
330,355
+195,211
+144% +$2.02M 0.05% 417
2022
Q4 		$1.27M Buy
135,144
+56,924
+73% +$254K 0.01% 1031
2022
Q3 		$213K Sell
78,220
-9,500
-11% -$31.1K ﹤0.01% 2296
2022
Q2 		$254K Buy
+87,720
New +$217K ﹤0.01% 1758
2019
Q3 		– Sell
-475,400
Closed -$3.95M – 1256
2019
Q2 		$3.95M Sell
475,400
-178,900
-27% -$1.53M 0.14% 179
2019
Q1 		$6.5M Buy
+654,300
New +$5.48M 0.23% 120

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Schonfeld Strategic Advisors's VKTX Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 53,683 shares worth $2.09M. The stake represents 0.01% of the portfolio and ranks #1046 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in VKTX as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in VKTX in Q1 2019 and has held it in 15 quarters since. The position peaked at $6.5M in Q1 2019. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Schonfeld Strategic Advisors held 53,683 shares of Viking Therapeutics worth $2.09M as of Q2 2026.
  • Viking Therapeutics was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Viking Therapeutics made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1046 holding.
  • Schonfeld Strategic Advisors first reported a position in Viking Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • Schonfeld Strategic Advisors's Viking Therapeutics position peaked at $6.5M in Q1 2019.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.